alpha-Eudesmol is an oxygenated sesquiterpene found in several woody and conifer-style oils in the AromaForge archive, including blue cypress, hinoki-type leaf oil, jade wood, carrot seed, and ginger lily profiles. The strongest public evidence around this constituent is identity and occurrence data plus a small preclinical pharmacology literature centered on calcium-channel-related neurophysiology and cell-culture apoptosis models. Those findings are early-stage and should be read as constituent research rather than a human-use claim.
Chemical identity and composition
PubChem classifies alpha-eudesmol as a eudesmane sesquiterpenoid and tertiary alcohol with formula C15H26O. In the local archive it appears as a recurring woody sesquiterpene alcohol in blue cypress, hinoki false cypress leaf oil, jade wood oil, carrot seed oil, and ginger lily oil.
Aroma and practical use
- Use the recorded woody, herbal, terpenic, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
neurogenic vasodilation
A PubMed-indexed study reported that alpha-eudesmol inhibited neurogenic vasodilation and extravasation after trigeminal-ganglion stimulation, consistent with calcium-channel-blocking activity in this preclinical model.
Measured: vasodilation and plasma extravasation
This experimental finding does not establish benefit, dose or safety in people using this blend.
brain injury related research
An abstracted rat study linked alpha-eudesmol's omega-agatoxin-IVA-sensitive calcium-channel blockade to protection against focal-ischemia-related brain injury in that experimental system.
Measured: brain-injury protection signal
This experimental finding does not establish benefit, dose or safety in people using this blend.
cell culture apoptosis research
A comparative cell study reported that alpha-, beta-, and gamma-eudesmol reduced proliferation and induced tumor-cell death through caspase-mediated apoptosis pathways in a human cholangiocarcinoma line.
Measured: cell proliferation and apoptosis markers
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedPublic identity and hazard sources reviewed in this pass did not surface a constituent-specific IFRA dermal limit for alpha-eudesmol.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
PubChem's laboratory chemical safety summary lists alpha-eudesmol as not classified for primary hazards, but that should not be treated as a broad finished-product safety clearance.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because the main bioactivity literature is preclinical and neuroactive, archive copy should avoid implying migraine, stroke, or other therapeutic effects.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
cav2 1 channel blockade
Rat synaptosome and oocyte work linked alpha-eudesmol to inhibition of omega-agatoxin-IVA-sensitive Ca2+ channels, with later comparative work describing use-dependent block of Cav2.1 channels by alpha- and gamma-eudesmol.
This experimental finding does not establish benefit, dose or safety in people using this blend.
caspase mediated apoptosis signal
In cultured cholangiocarcinoma cells, eudesmol isomers including alpha-eudesmol activated apoptotic pathways involving caspase-3, caspase-8, and caspase-9 signals.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical studies specific to isolated alpha-eudesmol were verified in the reviewed public sources.
- Most direct activity papers focus on laboratory or animal systems rather than typical aroma-use contexts.
- A July 2026 verification pass (RIFM Safety Assessment Program search and general web literature) did not locate a dedicated RIFM/IFRA fragrance ingredient safety assessment or authoritative dermal-limit figure for isolated alpha-eudesmol; constituent-specific sensitization, phototoxicity, and penetration-enhancement data also remain unlocated, so the existing 20% dermal_limit_pct and sensitizing:true flag stay unverified against a primary citation.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.